SHZ · 000518.SZ
Jiangsu Sihuan Bioengineering Co., Ltd
CN¥3.08-CN¥0.11 (-3.45%)
Jiangsu Sihuan Bioengineering Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 32.16% below the high.
Loading market information…
SHZ · 300966.SZ · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:04 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Hubei Goto Biopharm Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.46% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Hubei Goto Biopharm Co.,Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Hubei Goto Biopharm Co.,Ltd. is a Chinese enterprise specializing in the manufacture and distribution of active pharmaceutical ingredients (APIs) and intermediate compounds for steroid hormones. Its product line features essential starting materials such as 9a-hydroxy-4-androstenedione (9a-OHAD), bisnoralcohol (BA), sitolactone, 1,4-androstadienedione (ADD), and 4-androstenedione (4-AD). The company also provides a variety of intermediates, including those for estrogens, progesterone, non-steroidal substances, various other hormones, and corticosteroids. Furthermore, Hubei Goto Biopharm supplies additional raw materials for the pharmaceutical industry. The firm was established in Yicheng, China, in 2006.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:44 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥3.08-CN¥0.11 (-3.45%)
Jiangsu Sihuan Bioengineering Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 32.16% below the high.
CN¥21.10-CN¥0.08 (-0.38%)
Zhejiang East Asia Pharmaceutical Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 25.42% below the high.
CN¥7.31+CN¥1.22 (+20.03%)
Improve Medical Instruments Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 18.78% below the high.
CN¥3.53-CN¥0.23 (-6.12%)
Chengdu Huasun Technology Group Inc., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 31.46% below the high.
CN¥11.00-CN¥0.80 (-6.78%)
Shandong Sito Bio-technology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 32.39% below the high.
CN¥5.96-CN¥0.09 (-1.49%)
Jilin Jian Yisheng Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 38.43% below the high.
CN¥5.56-CN¥0.19 (-3.3%)
Hubei Guangji Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 46.64% below the high.
CN¥7.37-CN¥0.15 (-1.99%)
Guiyang Xintian Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.7% below the high.
